1Fornoni A,Ijaz A,Tejada T,et al.Role of inflammation in diabetic neohropathy.Curr Diabetes Rev,2008,4(1):10-17.
2lehinose K,Kawasaki E,Eguchi K.Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.Am J Nephrol,2007,27 (6):554-564.
3Kaysen GA,Eiserich JP.The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction.J Am Soc Nephrol,2004,15 (3):538-548.
4Tsirpanlis G,Bagos P,loannou D,et al.Exploring Inflammation in Hemodialysis Patients:Persistent and Superimposed Inflammation.A Longitudinal Study.Kidney Blood Press Res,2004,27 (2):63-70.
5Deppisch RM,Beck W,Goehl H,et al.Complement components as uremnic toxins and their potential role as mediators of microinflammation.Kidney Int Suppl,2001,78:S271-S277.
6Rdda E,Iddio D,Nicolai R,et al.The carnitin system and body composition.Acta Diabetol,2003,40(11):106-113.
7Calvan IM,Reda E.Regulation by camitine of myocardial fatty acid and carbohyrate metabolism under normal and pathological conditions.Basic Res Cardiol,2000,95(2):75-83.
8Davis PA,Momnino P,Savica V,et al.L-camitine,inflammation and hypertension.Nephrology (Carlton),2009,14(2):264-265.
1Hahn PF. Abolishment of alimentary lipemia following injection of heparin. Science, 1943,98 : 19 - 20.
2Santamarina - Fojo S, Dugl KA. Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr Opin Lipidol, 1994,5: 117 - 125.
3Lutz EP, Merkel M, Kako Y, et al. Heparin - binding defective lipoprotein lipase is unstable and causes abnormalities in lipia delivery to tissues. J Clin Invest, 2001, 107: 1183- 1192.
4Hodis HN, Mack WJ, Azen SO, et al. Triglyceride - and cholesterol - rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation, 1994, 90:42 - 49.
5Shimada M, Shimano H, Gotoda T, et al. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet - induced hypertriglyceridemia and hypercholesterolemia. J Biol Chem, 1993, 268 : 17924 - 17929.
6Shimada M, Ishibashl S, Inaba T, et al. Suppression of diet - induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. PNAS, 1996, 93:7242 - 7246.
7Zsigmund E, Kobayashi K, Tzung K, et al. Adenovirus - mediated gene transfer of human lipoprotein lipase ameliorates the hyperllpidemia associated with Apolipoproteins E and LDL receptor deficienties in Mice. Hum Gene Ther, 1997, 8 : 1921 - 1933.
8Michael Gaziano J, Hennekens CH, Odonnell C J, et al. Fasting triglycerides, high - density lipoprotein, and risk of myocardial infartion. Circulation, 1997, 96:2520-2525.
9Zilversmit DB. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride - rich lipoproteins. Circ Res, 1973, 33:633 -638.
10Babaev VR,Fazlo S, Gleaves L. A. , et al. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest, 1999, 103: 1697- 1705.
6Ichinose K, Kawasaki E, Eguchi K. Recent advancement of under- standing pathogenesis of type 1 diabetes and potential relevance to dia- betic nephropathy.Am J Nephrol, 2007,27 (6) : 554-564.
7Festa AD, Agostino R, Howard G, et al. Inflammation and microalbu- minuria in non-diabetes and type 2 diabetes subject The Insulin Resis- tance Atherosclerosis Study[J]. Kidney Int,2000,58(66) : 1703-1710.
8Rdda E,Iddio D,Nicolai R,et al. The carnitin system and body compo- sition[J]. Aeta Diabeto1,2003,40( 11 ) : 106-113.
9Calvan IM, Reda E. Regulation by carnitine of myocardial fatty acid and carbohyrate metabolism under normal and pathological conditions. fJ1. Basic Res Cardiol.2000.95(2):75-83.
10Davis PA, Mormino P ,Savica V, et al. L-carnitine ,inflammation and hy- pertension[J]. Nephrology (Carlton), 2009,14 (2) : 264-265.
